SCHEMBL9601411

SCHEMBL9601411

Cc1nc(-c2ccccc2)cc(-c2cccc([N+](=O)[O-])c2)c1C(=O)NCCN1CCOCC1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.52
ALDH1A1 P00352 4/20 0.50
HPGD P15428 4/20 0.50
KMT2A Q03164 3/20 0.50
KDM4E B2RXH2 3/20 0.50
MEN1 O00255 2/20 0.50
HTT P42858 1/20 0.50
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
POLB P06746 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CD274 Q9NZQ7 1/20 0.48
KDM5B Q9UGL1 1/20 0.47
NPC1 O15118 1/20 0.47
MTOR P42345 1/20 0.47
IRAK1 P51617 1/20 0.47
IRAK4 Q9NWZ3 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HPGDS O60760 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9603062 0.99 LMNA (0.52) LMNAALDH1A1HPGDKMT2AKDM4E
Hydrochloric Acid SCHEMBL9873583 0.99 LMNA (0.52) LMNAALDH1A1HPGDKMT2AKDM4E
SCHEMBL9779635 0.97 LMNA (0.52) LMNAALDH1A1HPGDKMT2AKDM4E
SCHEMBL10339856 0.96 SMN1; SMN2 (0.53) LMNAALDH1A1HPGDKDM4EHTT
Hydrochloric Acid SCHEMBL9779403 0.96 LMNA (0.52) LMNAALDH1A1HPGDKMT2AKDM4E
SCHEMBL9779265 0.94 LMNA (0.50) LMNAALDH1A1HPGDKMT2AKDM4E
SCHEMBL9602759 0.90 POLB (0.44) LMNAALDH1A1KMT2AMEN1HTT
SCHEMBL9779606 0.89 LMNA (0.49) LMNAALDH1A1KMT2AKDM4EMEN1
SCHEMBL9779556 0.88 LMNA (0.51) LMNAALDH1A1HPGDKMT2AKDM4E
SCHEMBL9779416 0.88 KMT2A (0.52) LMNAALDH1A1HPGDKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0311322-B1 PYRIDINE OR PYRIDAZINE DERIVATIVES AS CARDIO-PROTECTIVE AGENTS AND FOR THE TREATMENT OF ISCHEMIC DISEASE, AND PROCESS FOR THEIR PREPARATION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-07-21 EP claimed
US-4857527-A HYPOTENSIVE, ANTISCHEMIC AGENT FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-08-15 US claimed
EP-0311322-A2 Pyridine or pyridazine derivatives as cardio-protective agents and for the treatment of ischemic disease, and process for their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-12 EP claimed
EP-0311322-B1 PYRIDINE OR PYRIDAZINE DERIVATIVES AS CARDIO-PROTECTIVE AGENTS AND FOR THE TREATMENT OF ISCHEMIC DISEASE, AND PROCESS FOR THEIR PREPARATION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-07-21 EP disclosed
US-4990507-A Cardiotonic agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-02-05 US disclosed
EP-0228845-B1 N-CONTAINING HETEROCYCLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND COMPOSITION COMPRISING THE SAME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-12-12 EP disclosed
US-4931453-A CARDIOVASCULAR, HYPOTENSIVE AGENTS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-06-05 US disclosed
US-4857527-A HYPOTENSIVE, ANTISCHEMIC AGENT FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-08-15 US disclosed
US-4831030-A FOR CEREBROVASCULAR DISEASES; HYPERTENSIVE AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-05-16 US disclosed
EP-0311322-A2 Pyridine or pyridazine derivatives as cardio-protective agents and for the treatment of ischemic disease, and process for their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-12 EP disclosed
EP-0228845-A2 N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-07-15 EP disclosed